pO(two) not clearly show a rise in the ischemic or regular hemispheres despite reducing the infarct sizeThese benefits differ noticeably from Individuals documented by Maalej et al. [24], who demonstrated a discount in central macular thickness (CMT) and stabilization of DR lesions in patients who gained HBOT. In their review, patients with NPDR ha